It is generally accepted that a community of beneficial bacteria make up the lung microbiome, but their origin and formation have remained unclear — until now.
Regenerating nerves with an mRNA therapy
Stimulating neuron growth using a new mRNA therapy, researchers hope to treat chronic pain caused by disease, injury, or chemotherapy.
Broad-spectrum antivirals made from polymers
Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.
Decoy particles trick SARS-CoV-2
Using nanoparticles fitted with ACE2 receptors, researchers hope to lure SARS-CoV-2 away from healthy cells to inhibit the virus and treat infection.
Vaccine misinformation moderately curbed by new Facebook policy
New study provides evidence that social media companies have the tools to reduce the impact of vaccine misinformation on their platforms.
Researchers develop Raman barcodes to keep track of SARS-CoV-2 variants
A fast and efficient means of record keeping could improve the ability to trace structural differences in viral variants.
Omicron reduces vaccine efficacy, but boosters improve protection
Preliminary data indicates that booster shots improve antibody levels 25-fold compared to just two doses.
Real progress made this year in the fight against malaria
Antibody therapies and new vaccines have been added to the arsenal, giving hope to the millions who live where malaria is endemic.
New Pfizer and Merck antivirals look hopeful
With SARS-CoV-2 continuing to circulate, new oral antivirals promise to be game changers in helping to end the pandemic.
Conducting polymers go viral
Researchers have used helical virus particles as chiral templates for growing polymers with magnetic properties.